4 min read
Study Design by Therapeutic Modality in Shared Preclinical Models
The pain and neurology pipeline comprises several distinct therapeutic modalities. A neuropathic pain program today may...
Nov 10, 2026by MD Biosciences
The pain and neurology pipeline comprises several distinct therapeutic modalities. A neuropathic pain program today may...
Nov 3, 2026by MD Biosciences
Remyelination trials in multiple sclerosis are judged on imaging and functional endpoints because myelin cannot be...
Oct 27, 2026by MD Biosciences
Pain is a principal presenting symptom of rheumatoid arthritis, and persistent pain despite low inflammatory activity...
Oct 20, 2026by MD Biosciences
The clinical value of a non-opioid analgesic is defined relative to the established agents it is intended to replace,...
Oct 13, 2026by MD Biosciences
Multiple sclerosis therapy has been transformed by agents that control inflammation, and the unmet need has shifted...